Orthofix Medical Inc. (OFIX)
NASDAQ: OFIX · Real-Time Price · USD
10.42
-1.78 (-14.59%)
At close: Aug 5, 2026, 4:00 PM EDT
10.54
+0.12 (1.15%)
Pre-market: Aug 6, 2026, 7:59 AM EDT

Orthofix Medical Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-61.72-92.19-126-151.4-19.75-38.38
Depreciation & Amortization
52.7977.3260.0653.0629.0229.6
Stock-Based Compensation
28.6628.6932.4635.7118.4415.43
Other Adjustments
30.4941.0378.5270.844.8947.35
Change in Receivables
-10.75-1.58-9.53-10.41-6.74-7.05
Changes in Inventories
-25.78-10.75-5.55-58.05-33.04-10.21
Changes in Accounts Payable
12.222.6-5.578.642.284.25
Changes in Accrued Expenses
-3.29-2.279.534.070.631.01
Changes in Unearned Revenue
-----4.79-9.06
Changes in Other Operating Activities
-5.01-9.5-8.141.79-2.49-14.47
Operating Cash Flow
16.2733.3525.79-45.75-11.5418.48
Operating Cash Flow Growth
-43.23%29.30%----75.13%
Capital Expenditures
-44.09-34.63-34.88-62.05-21.36-17.79
Purchases of Intangible Assets
-----1.8-1.81
Purchases of Investments
------2.17
Proceeds from Sale of Investments
--7.4---
Cash Acquisitions
---29.42-1.5-
Other Investing Activities
0.160.03-0.1-0.50.13-1.25
Investing Cash Flow
-43.93-34.6-27.58-33.13-24.53-23.01
Long-Term Debt Issued
64.03-197.6174.5--
Long-Term Debt Repaid
---142.5-105.9--
Net Long-Term Debt Issued (Repaid)
64.03-55.168.6--
Issuance of Common Stock
5.55.936.265.134.348.82
Repurchase of Common Stock
-0.42-0.43-5.31-4.4-1.73-2.56
Net Common Stock Issued (Repurchased)
5.085.50.950.732.616.27
Other Financing Activities
-0.47-6.28-5.34-4.01-2.69-9.89
Financing Cash Flow
63.65-0.7950.7165.32-0.08-3.62
Foreign Exchange Rate Adjustments
-0.271.41-0.940.62-1-0.82
Net Cash Flow
35.72-0.6247.98-12.94-37.15-8.97
Free Cash Flow
-27.82-1.28-9.09-107.8-32.90.69
Free Cash Flow Growth
------98.83%
FCF Margin
-3.34%-0.16%-1.14%-14.44%-7.14%0.15%
Free Cash Flow Per Share
-0.69-0.03-0.24-2.94-1.630.03
Levered Free Cash Flow
-10.87-69.41-55.44-135.33-49.5-55.04
Unlevered Free Cash Flow
-52.83-59.89-70.61-194.19-44.55-40.31
SEC Filings: 10-K · 10-Q